Gregory S. Martini
Chief Financial Officer · Kyverna Therapeutics, Inc.
- 2025
- May 20, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gregory S. Martini files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alexander J. Denner - $20.53M in IRWD purchases and sales in the last 12 months
- Ronald Silver - $831K in IRWD purchases and sales in the last 12 months
- Thomas A. McCourt - $740K in IRWD purchases and sales in the last 12 months
- Karen Marie Walker - $293K in KYTX purchases and sales in the last 12 months
- Minardo John - $136K in IRWD purchases and sales in the last 12 months
- Michael Shetzline - $122K in IRWD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gregory S. Martini?
Gregory S. Martini is a corporate insider, tracked as Chief Financial Officer of Kyverna Therapeutics, Inc. (KYTX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Gregory S. Martini last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 4 filings going back to 2025.
Has Gregory S. Martini been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($83K) across all tracked filings.
